← Search & browse all drugs
RESPIRATORY SYSTEM › DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › Other systemic drugs for obstructive airway diseases
eprozinol
R03DX02
Forms & Strengths
- Oral tablets 30mg
- Oral solution 30mg/5mL
- Suppositories 30mg
Adult Dosing
- Oral: 30mg to 60mg three times daily
- Suppository: 30mg to 60mg two to three times daily
Pediatric Dosing
- Safety and efficacy in pediatric patients not established
Indications
- Bronchial asthma
- Chronic bronchitis
- Bronchospasm associated with respiratory tract disorders
Mechanism of Action
- Acts as a bronchodilator and respiratory stimulant
- Exhibits antihistaminic and anti-inflammatory properties on airway smooth muscle
Contraindications
- Hypersensitivity to eprozinol or its excipients
- Acute myocardial infarction
- Severe tachyarrhythmias
- First trimester of pregnancy
Adverse Reactions
- Nausea and gastrointestinal upset
- Dizziness
- Headache
- Palpitations or tachycardia
Drug Interactions
- Potential synergistic effects with other sympathomimetic bronchodilators
- Enhanced cardiac risk when co-administered with general anesthetics or monoamine oxidase inhibitors
Curated Content: Needs Vetting Before Put to Clinical Use